UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.226

Sortiert nach

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

International journal of clinical practice (Esher), 2010-04, Vol.64 (5), p.562-576

2010

Volltextzugriff (PDF)

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

International Journal of Obesity, 2010-05, Vol.34 (5), p.919-935

2010

Volltextzugriff (PDF)

clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

International Journal of Obesity, 2010-08, Vol.34 (8), p.1243-1254

2010

Volltextzugriff (PDF)

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes

International journal of clinical practice (Esher), 2011-02, Vol.65 (2), p.154-164

2011

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

International journal of clinical practice (Esher), 2011-09, Vol.65 (9), p.930-938

2011

Volltextzugriff (PDF)

Finasteride increases anagen hair in men with androgenetic alopecia

British journal of dermatology (1951), 2000-10, Vol.143 (4), p.804-810

2000

Volltextzugriff (PDF)

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

Diabetes, obesity & metabolism, 2011-02, Vol.13 (2), p.160-168

2011

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-02, Vol.12 (2), p.167-177

2010

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-05, Vol.12 (5), p.442-451

2010

Volltextzugriff (PDF)

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-03, Vol.12 (3), p.252-261

2010

Volltextzugriff (PDF)

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome

Diabetes, obesity & metabolism, 2011-06, Vol.13 (6), p.498-504

2011

Volltextzugriff (PDF)

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

Diabetes, obesity & metabolism, 2008-07, Vol.10 (7), p.545-555

2008

Volltextzugriff (PDF)

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Diabetes, obesity & metabolism, 2011-07, Vol.13 (7), p.644-652

2011

Volltextzugriff (PDF)

Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men

Dermatologic surgery, 1998-12, Vol.24 (12), p.1330-1332

1998

Volltextzugriff (PDF)

Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor

Biochemical and biophysical research communications, 1989-12, Vol.165 (3), p.1184-1190

1989

Volltextzugriff (PDF)

Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone-a factorial study

Diabetes, obesity & metabolism, 2014-03, Vol.16 (3), p.223-230

2014

Volltextzugriff (PDF)

Androgen metabolism as it affects hair growth in androgenetic alopecia

Dermatologic clinics, 1996-10, Vol.14 (4), p.697

Kaufman, K D

1996

Volltextzugriff (PDF)

A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

Diabetes, obesity & metabolism, 2011-09, Vol.13 (9), p.841-849

2011

Volltextzugriff (PDF)

Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2012-01, Vol.14 (1), p.67-76

2012

Volltextzugriff (PDF)

A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus

International journal of clinical practice (Esher), 2015-06, Vol.69 (6), p.626-631

2015

Volltextzugriff (PDF)

Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2012-05, Vol.14 (5), p.409-418

2012

Volltextzugriff (PDF)

Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men

The Journal of urology, 1999-10, Vol.162 (4), p.1295

1999

Volltextzugriff (PDF)

Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study

Diabetes, obesity & metabolism, 2012-08, Vol.14 (8), p.745-752

2012

Volltextzugriff (PDF)

one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes

Diabetes, obesity & metabolism, 2010-06, Vol.12 (6), p.517-531

2010

Volltextzugriff (PDF)

Long-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetes

Current medical research and opinion, 2015-06, Vol.31 (6), p.1071-1077

2015

Volltextzugriff (PDF)

1 – 25 von 2.226

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.995)
Mit Volltextzugriff
(1.911)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.362)
Life Sciences & Biomedicine
(1.144)
Humans
(1.017)
Female
(654)
Male
(610)
Biological And Medical Sciences
(554)
Medical Sciences
(475)
Adult
(390)
Middle Aged
(386)
Aged
(259)
Animals
(218)
Adolescent
(206)
Physical Sciences
(180)
Child
(153)
Physics
(142)
Treatment Outcome
(137)
Oncology
(130)
Surgery
(127)
Risk Factors
(118)
Fundamental And Applied Biological Sciences. Psychology
(101)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes

Finasteride increases anagen hair in men with androgenetic alopecia

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men

Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor

Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone-a factorial study

Androgen metabolism as it affects hair growth in androgenetic alopecia

A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes

A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus

Initial therapy with the fixed-dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes

Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men

Efficacy and safety of initial combination therapy with sitagliptin and pioglitazone in patients with type 2 diabetes: a 54-week study

one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes

Long-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetes

Aktive Filter

Suchergebnisse filtern